Applied Physiology, developer of advanced cardiovascular care systems for circulatory management in critical care, seeks European distributors in preparation for a 2010 market launch of the Navigator medical device.
Ideally distributors should already be selling monitoring systems into intensive care and cardiology units. Of particular interest is the UK, German and Scandinavian markets.
The Navigator technology from Sydney and London based Applied Physiology Pty Ltd, addresses the problem of clinician cognitive overload by simplifying the cardiovascular care of critical patients.
Raw data is acquired from conventional monitoring devices. These data are then used to calculate volume, resistance and cardiac output – key parameters that help clinicians to understand and manage cardiovascular performance. The interpreted data is then presented graphically on a bedside touch screen. The graph shows the patient’s status relative to clinician defined targets. In this way the care team is able to closely plan and monitor the effect of interventions.
Navigator is useful in any situation in which resuscitation, stabilization and optimization of hemodynamic and oxygen metabolism is required, including ICU, OR and emergency medicine.
Safety and effectiveness were established in a 2008 multi-centre randomised controlled trial. Navigator is well positioned for market launch in 2010.
Applied Physiology will exhibit at the annual MEDICA conference in Düsseldorf 18-21 November, 2009. To see Navigator or meet with company executives, visit the Australian Pavilion, Hall 17 Stand B58 or see: www.appliedphysiology.com.au
This device is not available for sale or distribution. Regulatory applications have been lodged.